Global Lung Cancer Surgery Market to reach USD 7.0 billion by 2027. Global Lung Cancer Surgery Market is valued at approximately USD 5.4 billion in 2020 and is anticipated to grow with a healthy growth rate of more than 3.8 % over the forecast period 2021-2027. Technological developments in lung cancer therapy, rising prevalence and incidence of lung cancer, increasing tendency of smoking tobacco, rising elderly population, rising emphasis on early cancer detection and treatment, and reimbursement availability are all driving market expansion. According to data published by World Health Organization in 2018, Cancer is the world's second-leading cause of death, with 10 million fatalities in the year 2020. Cancer is responsible for around 1 in every 6 deaths worldwide. In 2020, 19.3 million new cases were reported. The rise in cancer incidence on a global scale also points to an increase in the prevalence of lung cancers around the world. The rising incidence and prevalence of cancer, combined with a favorable financial environment and effective treatment options, is projected to increase the number of patients choosing for lung cancer surgery in the future years. This, in turn, is likely to fuel market expansion in the following years. However, high cost of lung cancer diagnosis & surgery may impede market growth over the forecast period of 2021-2027.

The regional analysis of the global Lung Cancer Surgery Market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America, and Rest of the World (ROW). North America is the leading region across the world in terms of market share due to increasing technological innovations in lung cancer treatment, rising incidence and frequency of lung cancer in the region. Whereas Asia Pacific is also anticipated to exhibit the highest growth rate over the forecast period 2021-2027, due to increasing trend of smoking tobacco, growing emphasis on early diagnosis & treatment of cancer across the region.

Major market player included in this report are:

Accuray Inc.
AngioDynamics Inc.
Ethicon US, LLC
Intuitive Surgical Inc.
Olympus Corporation
Teleflex Incorporated
Ackermann Instrumente GmbH
Scanlan International Inc.
Siemens Healthcare
Richard Wolf GmbH

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Surgical Devices:
Surgical Instruments
Monitoring & Visualising Systems
Endosurgical Equipment
By Surgical Procedures:
Thoracotomy
Minimally Invasive Surgeries
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year - 2017, 2018-19
Base year - 2019-2020
Forecast period - 2021 to 2027.

Target Audience of the Global Lung Cancer Surgery Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors